Nutriband inc. reports revenue up 56% in fiscal 2022 to a record $1.4m

Orlando, fla. , april 29, 2022 /prnewswire/ -- nutriband inc. (nasdaq: ntrb), a developer of transdermal pharmaceutical products, today announced financial and operational results for the fiscal year ended january 31, 2022.

NTRB Ratings Summary

NTRB Quant Ranking